PACKAGE LEAFLET: INFORMATION FOR THE USER
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%, solution for infusion
Active substances: sodium chloride and potassium chloride
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
This medicine is called “Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%, solution for infusion”, but will be referred to as Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% throughout this leaflet.
Contents of the pack:
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% is a solution of sodium chloride and potassium chloride in water. Sodium chloride and potassium chloride are chemical substances (commonly called salts) that are found in the blood.
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% is used to treat and prevent:
In situations that may cause loss of water and sodium chloride, including:
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% should not be given to you if you have any of the following conditions:
Warnings and precautions
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% is a hypertonic solution (concentrated). Your doctor will take this into account when calculating the amount of solution to be given to you.
Tell your doctor if you have or have had any of the following conditions:
This may increase the risk of low sodium levels in the blood and may cause headache, nausea, seizures, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you are being given this solution, your doctor may take blood and urine samples to check:
Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by infusion into a vein). During prolonged treatment with Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%, you may need to be given extra nutrition.
Other medicines and Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%
Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.
It is particularly important that you tell your doctor if you are taking:
Using Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% with food and drink
Ask your doctor about what you can eat or drink.
Fertility, pregnancy, and breastfeeding
Consult your doctor or pharmacist before using any medicine. Tell your doctor if you are pregnant or breastfeeding.
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% can be used during pregnancy. The amount given to you will be carefully controlled by your doctor.
If another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% does not affect your ability to drive or use machines.
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% will be given to you by a doctor or nurse. Your doctor will decide how much you need and when you will be given it, depending on your age, weight, medical condition, and biological condition, and your state of hydration (the amount of water in your body). The amount you receive may also be influenced by other treatments you are receiving.
DO NOT receive Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% if there are particles floating in the solution or if the container is damaged in any way.
The infusion rate will be decided by your doctor.
If you require a large volume or rapid infusion of Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%, your doctor may monitor your ECG (heart graph).
Generally, Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% will be given to you through a plastic tube connected to a needle in a vein, usually in your arm. However, your doctor may use another method to give you the medicine.
Before and during the infusion, your doctor will check:
If you have kidney failure, you will receive a lower dose.
Any unused solution should be discarded. You should NOT receive Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% from a bag that has been partially used.
If you receive more Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% than you should
If you are given too much Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% (overdose), the following symptoms may occur:
If you notice any of these symptoms, you should tell your doctor immediately. Your infusion will be stopped and you will be treated depending on the symptoms.
If a medicine has been added to the infusion solution before the overdose, this medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
If you stop the infusion of Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%
Your doctor will decide if you should stop receiving this infusion.
If you have any further questions on the use of this product, ask your doctor.
Like all medicines, Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% can cause side effects, although not everybody gets them.
The side effects that may occur due to the administration technique include:
If a medicine has been added to the infusion solution, it may also cause side effects. These side effects will depend on the added medicine. You should read the list of possible symptoms in the package leaflet of the added medicine.
Tell your doctor or nurse if you notice any of the side effects listed or any other. If any of these occur, the infusion should be stopped.
Reporting of side effects:
If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% does not require special storage conditions.
DO NOT use this medicine after the expiry date which is stated on the bag after EXP. The expiry date is the last day of the month shown.
You should not receive Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% if there are particles floating in the solution or if the container is damaged in any way.
Composition of Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15%
The active ingredients are:
The only excipient is water for injectable preparations
Appearance of the Product and Container Contents
Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% is a clear, particle-free solution. It is presented in polyolefin/polyamide (Viaflo) plastic bags. Each bag is packaged in a sealed protective plastic overbag.
The bag sizes are:
The bags are delivered in boxes, each containing the following quantities:
Not all packaging sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Holder
Baxter S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Manufacturer:
Baxter SA
Boulevard René Branquart, 80
7860 Lessines, Belgium
or
Bieffe Medital S.A.
Ctra. Biescas-Senegüé,
22666 Sabiñánigo (Huesca), Spain
Date of Last Revision of this Leaflet: February 2019
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
……………………………………………………………………………………………………
This information is intended only for healthcare professionals
Handling and Preparation
Use only if the solution is clear, free of visible particles, and if the container is not damaged. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the product's sterility.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air drawn from the primary container before the liquid contained in the secondary container is completely administered.
The solution must be administered with sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air from entering the system.
Medicines can be introduced before or during infusion through the injection point. When adding medicines, it is essential to check isotonicity before parenteral administration. It is crucial that the mixing of products is done under extreme asepsis conditions. Solutions containing added medicines should be used immediately and not stored.
After adding medicines, do not use the solution if there is a change in color and/or the appearance of precipitates, insoluble complexes, or crystals.
The addition of other medicines or the use of an incorrect administration technique can cause the appearance of febrile reactions due to the possible introduction of pyrogens. In case of an adverse reaction, the infusion must be interrupted immediately.
Discard after a single use.
Discard unused remains.
Do not reconnect half-used bags.
Use sterile material for preparation and administration.
The solution should not be administered in the atrium or ventricle to prevent localized hyperkalemia but should be administered in large peripheral or central veins to reduce the risk of sclerosis.
Warning: Added medicines may be incompatible. (See the section below "Incompatibilities of Added Medicines")
To Add Medication Before Administration
Precaution: Do not store bags with added medication.
To Add Medication During Administration
Before use, the physical and chemical stability of any additional medication in the pH of the Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% solution in the Viaflo container must be established.
From a microbiological point of view, the diluted product must be used immediately unless the addition of medicines has been carried out under aseptic and validated conditions. If it is not used immediately, the conditions and storage times used before its use are the responsibility of the user
As with all parenteral solutions, the incompatibility of added medicines with the solution in the Viaflo bag must be verified before addition.
In the absence of compatibility studies, this solution should not be mixed with other medicines.
It is the responsibility of the physician to judge the incompatibility of the added medication to Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% by examining any eventual change in color and/or occasional appearance of precipitate, insoluble complexes, or crystals. The leaflet of the medicine to be added should be consulted.
Before adding a medicine, verify that it is soluble and stable in water at the pH of the Viaflo Sodium Chloride 0.9% and Potassium Chloride 0.15% solution (pH: 4.5 – 7.0).
Medicines that are known to be incompatible should not be used.